MEGIN
  • About us
    • About us
    • Meet the team
  • Our solution
    • MEG Maps™ powered by TRIUX™ neo
    • Book a MEG Maps™ Demo
  • News & Education
    • News
    • MEGIN Spotlights
    • MEGIN Masterclass
    • Abstracts and studies
  • Patients
  • Find a MEG site
    • Global
    • North America
  • Get in touch
    • Contact us
    • Book a MEG Maps™ Demo
Select Page
Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk

Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk

by Naomi Devlin | Jun 6, 2025 | Masterclass - Translational Research

MEGIN Masterclass Time-resolved tracking of neuronal activity combined with artificial intelligence: Tools for predicting dementia risk Presented by Hanna Renvall (PhD) – Assistant Professor Dept. Neuroscience and Biomedical Engineering, Scientific Director of...
MEGIN Matters May 2025

MEGIN Matters May 2025

by Naomi Devlin | May 30, 2025 | MEGIN Matters

An adversarial collaboration for testing theories of consciousness

An adversarial collaboration for testing theories of consciousness

by Naomi Devlin | May 9, 2025 | Masterclass - Basic Research

MEGIN Masterclass An adversarial collaboration for testing theories of consciousness Presented by Oscar Ferrante, PhD and Ling Liu, PhD. Abstract: Different theories propose distinct mechanisms for how subjective experience emerges from brain activity, yet they have...
MEGIN Matters – April 2025

MEGIN Matters – April 2025

by Naomi Devlin | Apr 23, 2025 | MEGIN Matters

Accurate yet MRI-free magnetic source imaging with the pseudo-MRI engine

Accurate yet MRI-free magnetic source imaging with the pseudo-MRI engine

by Naomi Devlin | Apr 8, 2025 | Masterclass - Data Acquisition and Analysis

MEGIN Masterclass Accurate yet MRI-free magnetic source imaging with the pseudo-MRI engine Presented by Amit Jaiswal, PhD and Lauri Parkkonen, PhD. Abstract: Structural head MRIs are a crucial ingredient in MEG/EEG source imaging; they are used to define a...
« Older Entries
Next Entries »

Home
About us

MEG Maps™
Contact us
Subscribe to the newsletter

Insights & Education

News
MEGIN Spotlights
MEGIN Masterclass
Abstracts & studies

Patients

MEGIN China

Find a MEG site
Global
North America

Connect with us
  • Follow
  • Follow
  • Follow

Copyright 2026© – MEGIN
MEGIN’s new platform MEG Maps™ is powered by TRIUX™ neo and MEGreview™, which have 510(k) clearance from the US Food & Drug Administration (FDA) and are under EU MDR Notified body review, i.e. not available for commercial distribution in the EU area. For commercial distribution, please contact your local MEGIN representative. TRIUX™ neo is intended to non-invasively record brain activity, and when interpreted by trained physicians, to help localize these active areas. All other applications are scientific research in nature. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician
.